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(H.-C. Huang), yukijuan@ntu.edu.tw (H.-F. Juan).Neuroblastoma is the most common extracranial solid tumor in children. We investigate whether
miR-124, the abundant neuronal miRNA, plays a pivotal role in neuroblastoma. Knockdown of
miR-124 promotes neuroblastoma SK-N-SH cell differentiation, cell cycle arrest and apoptosis. Fur-
ther miR-124 is predicted to target aryl hydrocarbon receptor (AHR) which may promote neuroblas-
toma cell differentiation. We validate that miR-124 may suppress the expression of AHR by targeting
its 30-UTR. These results suggest that miR-124 could serve as a potential therapeutic target of
neuroblastoma.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Neuroblastoma, an embryonic tumor derived from the auto-
nomic nervous system neural-crest tissues, is the second most
common extracranial malignant tumor of childhood and the most
common solid tumor of infancy [1]. Neuroblastoma arises from fe-
tal precursors of the sympathetic nervous system [2]. Molecularchemical Societies. Published by E
ocarbon receptor; 30-UTR, 30-
or; Inh, anti-miR-124 miRNA
ock-Inh, inhibitor negative
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and Bioinformatics, National
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), hsuancheng@ym.edu.twdefects in differentiation are one of the causes in neuroblastoma
development.
MicroRNAs (miRNAs) are a class of small non-coding RNAs
approximately 21 nucleotides in length that regulate diverse cellu-
lar processes including decision of cell lineage, stem cell division,
development in evolutionarily divergent organisms, tumorigene-
sis, and tumor cell metastasis [3,4]. These evidences suggest that
miRNAs may be valuable therapeutic agents for their roles in mod-
ulating the differentiation of human tumor cells. MiR-124 is a con-
served miRNA that has been recorded in 60 organisms for 94
sequences in mirBase and been found to be abundant in nerve sys-
tem, endocrine gland, and embryo [5]. Most studies showed that
this neuronal abound miRNA could modulate the neurite out-
growth during neurogenesis and regulate the differentiation in
neuron. For instance, miR-124 can inhibit SCP1 expression in
embryonal carcinoma cell P19 and shows a complementary
expression pattern during spinal cord development [6]. Overex-
pression of miR-124 in P19 cells contributes to the control of neu-
rite outgrowth by regulation of the cytoskeleton remodeling [7]. In
the mouse neuroblastoma cell lines, CAD and Neuro2a, miR-124
promotes the differentiation by targeting PTBP1 mRNA encodes alsevier B.V. All rights reserved.
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cells [8]. During adult neurogenesis in mice, miR-124 is an impor-
tant regulator of the temporal progression along the subventricular
zone stem cell lineage to neurons [9] and during the apical to basal
transition of neural precursor cells in the mouse embryonic neo-
cortex [10].
However, the functions of miR-124 in neuronal differentiation
remain controversial. Cao et al. showed that experiments to alter
expression of miR-124 in neural cells did not appear to affect differ-
entiation in the chick neural tube [11]. In the early developmental
stage of optic cup formation in Xenopus, miR-124 targetingNeuroD1
plays an anti-neural role in promoting cell proliferation [12]. Fur-
thermore, the role of miR-124 in differentiation shows diversity in
a genome wide small RNA sequencing project. Upon differentiation
stimulation of retinoic acid (RA), transphorbol ester (TPA), dibutyryl
cAMP (dcAMP), or fetal bovine serum (FBS) withdrawn, the expres-
sion of miR-124 is upregulated in human SHSY5Y and mouse N1E-
115 neuroblastoma cells but downregulated in mouse Neuro2a
and NG-108 neuroblastoma cells [13]. Study of dysregulation in
miR-124 thus showed decisive in regulation of neuroblastoma.
Aryl hydrocarbon receptor (AHR) is a ligand-activated tran-
scription factor that residents in the cytoplasm as an inactive form
by binding of chaperon proteins such as 90 kDa heat shock protein
[14,15] and forms heterodimer with AHR nuclear translocator
(ARNT) [16] to activate xenobiotic response element located up-
stream of the target genes such as CYP1A1 due to activation of
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-related ligands bind-
ing and translocation into the nucleus [17,18]. Nevertheless, AHR
is postulated to play important roles not only in the regulation of
xenobiotic metabolism but also in the regulation of differentiation
in pro-inﬂammatory T cells [19], ketarinocytes [20], myeloblastic
leukemia cells [21], and Neuro2a cells [22].
Here in this study, we reveal an undescribed regulation of miR-
124 in neuroblastoma that loss of miR-124 resulted in upregula-
tion of AHR leading differentiation in the neuroblastoma cell line
SK-N-SH.2. Materials and methods
2.1. Patients and treatment
The clinical evaluation and use of tumor samples in each patient
were approved by the Institutional ReviewBoard ofNational Taiwan
University Hospital, Taipei. During a period of 16 years (from
December 1990 to December 2006), tissues were immediately fro-
zen and stored at 80 C prior to real-time RT-PCR analyses.
2.2. Cell culture
Neuroblastoma cell line SK-N-SH and SK-N-BE were maintained
in Dulbecco’s Modiﬁed Eagle’s Medium (DMEM)/F12 with 10%
(v/v) fetal bovine serum (FBS) (GIBCO, New York, USA). A549 cells
were maintained in DMEM. Cells were cultured at 37 C in a
humidiﬁed atmosphere containing 5% CO2.
2.3. miRNA transfection
Cells were seeded into six-well plates and transfected using
Turbofect™ in vitro Transfection Reagent (Fermentas, Burlington,
USA) according to the manual. Pre-miR-124 precursor (Pre), anti-
miR-124 miRNA inhibitor (Inh), precursor negative control
(Mock-Pre) and inhibitor negative control (Mock-Inh) were pur-
chased from Ambion Inc. (Austin, TX). Each of them was transfec-
ted into cells at a concentration of 200 nM as previous described
[23].2.4. RNA extraction and real-time RT-PCR
Total RNA was extracted from cells or tissues with Trizol re-
agent according to the instruction (Invitrogen, Carlsbad, USA).
The miR-124 level was quantiﬁed by quantitative real-time RT-
PCR using TaqMan MicroRNA Assay kits (Applied Biosystems, Fos-
ter City, USA) with U6 small nuclear RNA (snRNA RNU6B) as an
internal normalized reference. Their relative levels were measured
in triplicate on a Prism 7300 real-time PCR machine (Applied Bio-
systems). For the quantiﬁcation of AHR, GAP-43, CRT, and NSE, ex-
tracted RNA was reverse transcribed to cDNA using an oligo(dT)12
primer and RevertAid™ Reverse Transcriptase (Fermentas). Their
relative levels were measured in triplicate on a MyiQ Single-Color
Real-Time PCR Detection System (Bio-Rad, Hercules, USA) with
GAPDH as internal control.2.5. Luciferase reporter assay
The reporter constructs containing AHR 30-untranslated mRNA
region (30-UTR) were cloned into the pMIR-REPORT vector (Ambi-
on) using PCR-generated fragment. The mutated and deleted AHR
30-UTR were ampliﬁed from the Luc-AHR-WT vector. The reporter
assays were carried out as described previously with a transfection
control [23].2.6. Western blot analysis
Total cellular protein was separated by electrophoresis in SDS–
polyacrylamide gels before transfer to PVDF membrane (Millipore,
Bedford, MA, USA). Anti-GAP43, anti-AHR, and anti-Ki67 were ob-
tained from Abcam (Cambridge, UK), Santa Cruz (CA, USA), and
Millipore, respectively. Others were purchased from Cell Signaling
Technology (MA, USA). Signals were visualized by chemilumines-
cence using the ECL reagent (Millipore).2.7. Statistical analysis
Statistical analysis of miRNA expression in tumor cells was per-
formed on log2 transformed fold change data. Student’s t-test and
P-values were tested for multiple comparisons by controlling the
false discovery rate.3. Results and discussion
3.1. MiR-124 regulates neuroblastoma cell differentiation
To investigate the role of miR-124 in neuroblastoma, we per-
formed the loss- and gain-of-function of miR-124 in neuroblas-
toma cells. It was evident that the miR-124 inhibitor induced an
increase in the number of cells bearing neurites compared to con-
trol cells (Figs. 1A and S1). The changes in cell morphology and
neurite length observed in the presence of Inh suggested induction
of neuronal differentiation. To determine whether the Inh-induced
morphological changes were accompanied by biochemical patterns
resembling the neuronal phenotype, we measured the levels of
neuronal-speciﬁc markers including growth-associated protein
43 (GAP-43), calreticulin (CRT) and neuron-speciﬁc enolase (NSE)
by qRT-PCR. These three known differentiation markers were all
elevated after inhibition of miR-124 (Fig. 1B). In addition, the pro-
tein expression level of GAP43 is also strongly increased after inhi-
bition of miR-124 (Fig. 1C). The results suggest that miR-124 may
function as a cell fate regulator which modulates cell differentia-
tion in SK-N-SH cells.
Fig. 1. miR-124 inhibits neuroblastoma cell differentiation. (A) SK-N-SH cells transfected with 200 nM miR-124 precursor (Pre), negative control precursor (Mock-Pre), miR-
124 inhibitor (Inh) or negative control inhibitor (Mock-Inh) were observed by phase-contrast microscopy. Bar, 50 lm. (B) qRT-PCR analysis of three neuronal differentiation
markers, calreticulin (CRT), neuron-speciﬁc enolase (NSE) and growth-associated protein 43 (GAP-43) in SK-N-SH cells after transfected with Inh or Mock-Inh. ⁄P < 0.05. (C)
The protein expression level of GAP-43 were normalized to actin in SK-N-SH cells after transfected with Inh or Mock-Inh.
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SK-N-SH
Cell cycle arrest and cell death are tightly coupled to terminal
differentiation of neuroblastoma cells. Since neuroblastomas, as
well as their derived cell lines, maintain the potentiality of termi-
nal differentiation, we subsequently testify whether Inh can also
cause anti-proliferative effects including cell cycle arrest and apop-
tosis along with cell differentiation. To conﬁrm this possibility,
SK-N-SH cells were treated with Inh or Mock-Inh and subsequently
processed for FACS and immunoblotting analysis. Cytoﬂuorimetric
analysis revealed that there was an accumulation of a G0/G1-phase
population in miR-124 downregulated cells (Fig. 2A). Ki-67 is
routinely used as a marker of cell cycle progression and prolifera-
tion. We found that the expression level of Ki-67 was decreased in
Inh-transfected cells (Fig. 2B). We next investigated whether cell
cycle proteins were modulated in Inh-treated SK-N-SH cells byFig. 2. Anti-miR-124 induces cell cycle arrest in SK-N-SH cells. SK-N-SH cells were
transfected with 200 nM miR-124 inhibitor (Inh) or negative control inhibitor
(Mock-Inh). (A) DNA distributions of SK-N-SH cells after transfection were analyzed
by ﬂow cytometry and quantiﬁed by ModFit program. (B) The level of proliferation
marker Ki-67, (C) cell cycle regulators pRB, RB, cyclin D1, and CDK4 were examined
by Western blot and normalized to actin.immunoblotting experiments. Fig. 2B shows that Inh induced
dramatically decrease in cyclin D1 and CKD4. Moreover, the
expression proﬁle of cyclin and CDK was in agreement with the
hypo-phosphorylated/active form of Rb (Fig. 2C). We also observed
an increasing number of cells progressing programmed cell death
by annexin V/PI, DAPI staining, and immuneblotting in SK-N-SH
cells transfected with Inh. The Inh treated cells distributed increase
in annexin V positive population (Fig. 3A), showed shrinkage mor-
phology in nucleus (Fig. 3B) and decreased in the protein expres-
sion of procaspases and pro-PARP (Fig. 3C). These data revealed
that apoptosis was undergone in SK-N-SH cells after cell differen-
tiation through a caspase dependent pathway.
3.3. AHR is a direct target of miR-124
Using TargetScan 5.1 [24], miR-124 was predicted to target the
AHR 30-UTR (Fig. 4A). Since AHR has been shown to promote neu-
roblastoma cell differentiation [18,25,26], it is plausible that miR-
124 may affect neuroblastoma cell differentiation by targeting on
AHR. To demonstrate whether there was a direct targeting of
AHR by miR-124, Pre was cotransfected with a luciferase reporter
plasmid carrying 30-UTR of AHR in the form of wild type (WT),
mutation in the ﬁrst four miR-124 targeting site (mut), and dele-
tion of the seed region binding site (del) (Fig. 4A). The luciferase as-
say was performed in a neuroblastoma cell line SK-N-SH and a lung
adenocarcinoma cell line A549 lacking of endogenous miR-124
expression. In both cell lines, miR-124 only inhibited the luciferase
activity by approximately 30–40% in WT AHR, compared with the
activity of a negative control miRNA, which does not recognize any
potential target (Fig. 4B). Next, we determined whether changes in
miR-124 expression would modulate AHR expression. To this end,
we overexpressed miR-124 with Pre and knocked down its levels
with Inh in both SK-N-BE and SK-N-SH cell lines. The expression le-
vel of miR-124 was conﬁrmed by qRT-PCR after transfection
(Fig. 4C). The mRNA (Fig. 4C) and protein (Fig. 4D) expression level
of AHR was inhibited by Pre and elevated by Inh. The results
showed that miR-124 indeed regulated expression of AHR by di-
rectly targeting its 30-UTR.
Fig. 3. Anti-miR-124 induces apoptosis in SK-N-SH cells. After transfected with miR-124 inhibitor (Inh) or the negative control inhibitor (Mock-Inh) for 72 h, cells were
double-stained with annexin-V-FITC (AV) and propidium iodide (PI) for ﬂow cytometry analysis and stained with DAPI for nucleus observation. (A) Lower left quadrant shows
viable cells; lower right, AV+/PI cells (early apoptosis); upper left, AV-/PI+ cells (necrosis); upper right, AV+/PI+ cells (late apoptosis). The percentage of cells in the four
quadrants were quantiﬁed and plotted. ⁄P < 0.05. (B) Cells transfected with Inh showed shrinking morphology and condensed chromosome in nuclei were indicated by white
arrows. (C) The protein level of procaspase-9 and 3 and pro-PARP were examined by Western blot and normalized to actin.
Fig. 4. Down-regulation of AHR by miR-124 at mRNA and protein levels via direct targeting of 30-UTR. (A) The full length wild type AHR 30-UTR (WT), seed region mutated
(mut) and deleted (del) AHR were cloned into pMIR reporter. (B) Target of AHR 30-UTR by miR-124 were examined by luciferase reporter assay in SK-N-SH and A549 cells.
Both SK-N-SH and A549 cells were cotransfected with miR-124 precursor (Pre, open bar) or the scramble negative control (Mock-Pre, solid bar). Levels of (C) miR-124
expression and AHRmRNA and (D) AHR protein were examined after transfected with Pre, Mock-Pre, miR-124 inhibitor (Inh) or negative control inhibitor (Mock-Inh). (E) The
mRNA expression levels of AHR and miR-124 was assessed by qRT-PCR from thirteen neuroblastoma patients. Pearson’s correlation analysis was carried out to evaluate the
relationship between AHR and miR-124. The miR-124 and AHRmRNA expression levels were normalized to snRNA RNU6B and GAPDH. AHR protein levels were normalized to
actin. ⁄P < 0.05.
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Since AHR is one of the targets of miR-124, we next clarify the
association between miR-124 and AHR in vivo from 13 patients
with neuroblastoma. We found a signiﬁcantly reverse correlation
between miR-124 and AHR (Fig. 4E, Pearson’s correlation coefﬁ-
cient = 0.7 with a P-value less than 0.005). The results show that
the expressions miR-124 and AHR are complementary in clinic and
suggest that miR-124 might negatively regulate the expression of
AHR in neuroblastoma cells not only in vitro but also in vivo.
3.5. Concluding remarks
To date, miR-124 is a highly conserved miRNA that speciﬁcally
expressed in the nervous system of all animals studied. The role of
miR-124 is not only critical in the neuronal development, but also
in tumorigenesis. Recently, many reports show that AHR possesses
anti-cancer effects [25,26]. These studies support our ﬁndings that
inhibition of miR-124 caused increasing in AHR and resulted in cell
differentiation.
In summary, we found that withdrawal of miR-124 in SK-N-SH
neuroblastoma cells increases the protein expression level of AHR
with followed by inhibition of cell proliferation, blockage of cell cy-
cle at G0/G1 phase, differentiation in neuroblastoma cells, and
occurrence in programmed cell death. Herein, we suggest that
the involvement of miRNAs in neuroblastoma development can
be taken into consideration when applying differentiation therapy
in cancer treatments.
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